Nitric oxide (NO) functions as an intercellular messenger and mediates numerous biological functions. Among the three isoforms of NO synthase that produce NO, the ubiquitously expressed neuronal NO synthase (nNOS) is responsible for a large part of NO production, yet its regulation is poorly understood. Recent reports of two alternative spliceforms of nNOS in the mouse and in man have raised the possibility of spatial and temporal modulation of expression. This study demonstrates the existence of at least three transcripts of the rat nNOS gene designated nNOSa, nNOSb, and nNOSc, respectively, with distinct 5 Ј untranslated first exons that arise from alternative splicing to a common second exon. Expression of the alternative transcripts occurs with a high degree of tissue and developmental specificity, as demonstrated by RNase protection assays on multiple tissues from both fetal and adult rats. 
Introduction
Nitric oxide (NO) 1 is synthesized by nitric oxide synthase (NOS) during the NADPH-dependent conversion of L -arginine to L -citrulline. Three isoforms of NOS encoded by distinct genes have been identified. The neuronal and endothelial NO synthases (nNOS, eNOS) are calcium/calmodulin dependent; their expression has in the past been viewed as constitutive (1) (2) (3) (4) . In contrast, the inducible isoform (iNOS) isolated from macrophages is calcium/calmodulin-independent, and expression is induced by cytokine stimulation (5, 6) . NO is a multifunctional intercellular messenger affecting diverse aspects of mammalian physiology including regulation of vascular tone, macrophage-mediated cytotoxicity, neuronal differentiation, and synaptic plasticity (7) . While the transinteraction of cytokine-responsive elements within the promoter region is thought to affect the transcriptional regulation of the iNOS gene (8) , the mechanisms by which the ubiquitous expression of the nNOS gene is regulated are unknown.
The highest expression of nNOS in the rat has been demonstrated in the brain, in particular in the cerebellum. The gene is also expressed in skeletal muscle, in the myenteric plexus in the gut, in the macula densa of the kidney, and in the heart (9, 10) . Based on its widespread expression, nNOS is generally considered to be responsible for the largest proportion of tissue NO synthase activity. Although traditionally labeled constitutive, the expression of nNOS may in fact be tightly regulated, as suggested by a number of recent observations. nNOS expression was found to be subject to regulation by estrogen (11) , and was induced after axotomy, in parallel with an increased expression of the transcription factors jun and krox (12, 13) . Furthermore, transient changes in levels of expression of nNOS have been observed in the developing rat nervous system and lung (14, 15) . Likewise, the onset of nNOS expression in the developing tectum in chicken coincides with the onset of innervation by axons from retinal ganglion cells (16) .
Recently, two alternatively spliced nNOS transcripts arising from two alternative promoters and differing in their 5 Ј -untranslated regions (5 Ј UTR) have been described in human and murine nNOS genes (17, 18) . The use of multiple alternative promoters in conjunction with alternative splicing may represent a mechanism by which spatial as well as temporal regulation of nNOS gene transcription is achieved.
Here we present evidence for the presence of three differentially spliced nNOS variants in the rat as well as a comprehensive analysis of spatial and temporal expression patterns that further supports the notion that nNOS expression is modulated by specific and complex regulatory mechanisms on the transcriptional level.
Methods

Rapid amplification of cDNA ends (RACE).
Total RNA was extracted from frozen rat tissues by the guanidium thiocyanate-cesium chloride gradient method. Genomic DNA was removed by incubation with RNase-free DNase (Promega Corp., Madison,WI) followed by phenol/chloroform/isoamyl alcohol (25:24:1) extraction and ethanol precipitation. RACE was carried out as previously described (19) . In brief, first-strand cDNA was synthesized from 3 g total RNA of various tissues with primer N1 (5 Ј -ggcgtcatctgctcattccgattc-3 Ј ) located at position 211 of the published sequence for the rat nNOS gene (3), using Superscript II RNase H-Reverse Transcriptase (GIBCO BRL Life Technologies, Inc., Gaithersburg, MD). The cDNA was columnpurified, tailed with terminal transferase (Life Technologies, Inc.) in the presence of dCTP (Pharmacia Diagnostics AB, Uppsala, Sweden), and then amplified in two sequential rounds of nested PCR in a 25 l volume, containing 200 nM of each deoxynucleotide triphosphate, 2 mM magnesium chloride, 0.1 U Taq polymerase (Promega Corp.), 75 nM of a poly(G)-anchor primer, and 200 nM of the gene-specific primers N2 (5 Ј -tgtccccgcccccttccttactct-3 Ј ) or N3 (5 Ј -tcaggggcagcaacgggatgtgtc-3 Ј ), respectively. In each reaction, an initial denaturation for 2 min at 94 Њ C was followed by 35 cycles of 94 Њ C for 30 s, 58 Њ C for 1 min, and 72 Њ C for 2 min and a final extension at 72 Њ C for 10 min. Amplicons were fractionated on a 2% agarose gel, purified, and cloned into the PCRII vector using the TA Cloning Kit (Invitrogen Corp., San Diego, CA). Clones were sequenced with the Taq DyeDeoxy Terminator Cycle Sequencing Kit using primer N3 on an ABI373A automatic sequencer (Applied Biosystems Inc., Foster City, CA). All newly determined sequences have been deposited with the GenBank data base (accession numbers: AF008911, AF008912, AF008913).
RNase protection assay. cDNA clones obtained by RACE-PCR were linearized at appropriate restriction sites at the 5 Ј end of the insert. Complementary RNAs were transcribed from 1 g plasmid in the presence of [ ␣ -32 P]UTP (DuPont-NEN, Boston, MA) with SP6 RNA polymerase using the MAXIscript kit (Ambion Inc., Austin, TX). Labeled probes were purified over Chromaspin-100 columns (Clontech, Palo Alto, CA). RNase protection assay was carried out using the RPAII kit (Ambion Inc.). In brief, 100,000 cpm of labeled probe was hybridized against 100 g total RNA or tRNA overnight at 45 Њ C. Samples were digested with RNase A and T1, precipitated, and run on a 5.5% denaturing polyacrylamide gel.
Cell culture and reverse transcription PCR (RT-PCR)
. Differentiation of rat pheochromocytoma-derived PC12 cells into neurons was carried out as previously described (20). Cells were plated on poly-L -lysine coated dishes in DME supplemented with 10% horse serum and 5% FCS (Life Technologies, Inc.) at a density of 5 ϫ 10 5 cells per 10-cm dish. After 16 h the medium was changed, and 50 ng/ml nerve growth factor (NGF; Sigma Chemical Co., St. Louis, MO) was added. Neurite outgrowth development was monitored by light microscopy. After 9 d cells were washed twice with 1 ϫ PBS, and total RNA was extracted using the RNeasy kit (QIAGEN Inc., Chatsworth, CA). 3 g RNA was reverse transcribed in the presence of 1 g oligo(dT) and 50 ng random hexanucleotide primers using Superscript II RNase H-Reverse Transcriptase (Life Technologies, Inc.). PCR was carried out as described above after validation that under these conditions PCR product accumulation remained in the exponential phase using 200 nM of each sense and antisense primer. Isoform-specific sense oligonucleotides for nNOSa (A1 5 Ј -agcgggatccacagccctggaact-3 Ј ), nNOSb (B1 5 Ј -gactgaggggcgacactaccatgc-3 Ј ), and nNOSc (C1 5 Ј -caccacagcctctggaatgaaaga-3 Ј ), respectively, were combined with the common antisense primer N1. A cDNA pool derived from brain, embryo, and kidney was included as positive control. To monitor expression of a housekeeping gene exon spanning oligonucleotides of the rat ␤ -actin gene (ract1 5 Ј -gaccttcaacaccccagccatg-3 Ј ; ract2 5 Ј -gggccggactcatcgtactcct-3 Ј ) and were used to amplify a 726-bp fragment during 25 cycles of PCR (21) . Amplicons were fractionated on 2% agarose gels and blotted onto nylon membrane. Southern blot analysis was performed with the internally located oligonucleotide N3 labeled with [ ␥ -32 P]ATP using T4 polynucleotide kinase (New England Biolabs Inc., Beverly, MA).
Screening of a rat yeast artifical chromosome library. PCR amplification of screening pools of a rat YAC library (22) was carried out using oligonucleotide sets specific for the alternative first exons of nNOSa (Ay1 5 Ј -ggcgctgttggagcccggagca-3 Ј ; Ay2 5 Ј -ctgctgccgagcccgcgcagtt-3 Ј ), and nNOSb (By1 5 Ј -ccttgagtcgctcggccgcaccat-3 Ј ; By2 5 Ј -ggactcctgcgaagccgtcccttg-3 Ј ) as well as for the 5 Ј end (5end1 5 Ј -cgtctgacaagctggtgaccaaga-3 Ј ; 5end2 5 Ј -gaacctccagggcactgtcatagc-3 Ј ) and 3 Ј end (3end1 5 Ј -ggctctcacaaaaccgcatcctc-3 Ј ; 3end2 5 Ј -aaagagggtggttgggggcttaa-3 Ј ) of the published nNOS cDNA sequence. A single YAC, 228H7, was found that yielded specific amplification products for all primer sets tested. YAC DNA was isolated from yeast cells embedded in agarose plugs (22) and digested overnight with each of the restriction endonucleases Pac I, Pme I, Sfi I, and Sap I (New England Biolabs) or with combinations thereof. Subsequently, plug DNA was size-fractionated by pulsed field gel electrophoresis in a 1% agarose gel in 0.5 ϫ TBE at 14 Њ C, 6V/cm for 18 h with a switching time of 15 s and blotted onto nylon membrane. Total rat genomic DNA was included as control. Southern blot analysis was performed with probes generated by PCR using the same primers as for the library screening. Probes were labeled with [ ␣ - 
Results
Isolation of multiple nNOS transcripts with unique 5 Ј UTRs.
Cloning and sequencing of cDNA by RACE from brain, kidney, heart, intestine, and embryo led to the identification of three different nNOS mRNA species that are designated as nNOSa, nNOSb, and nNOSc. nNOSa was overall the most abundant isoform, found especially in the brain, while nNOSb was almost exclusively expressed in embryonal tissue and nNOSc in the kidney. A common 3 Ј terminal sequence consisting of 30 bp was found to be shared by all isoforms extending 5 Ј from position ϩ 2 of the published sequence of the rat nNOS cDNA (3) . Based on PCR analysis of genomic DNA, this 30-bp common sequence is contiguous with the published 5 Ј end of the gene, and therefore represents the actual 5 Ј end of the second exon (previously perceived as the first exon) of the rat nNOS gene. The unique additional 5 Ј terminal sequences represent differential exon 1 sequences of nNOSa, nNOSb and nNOSc that are spliced to this newly identified 30-bp domain of the second exon (Fig. 1) . The newly identified unique first exons of nNOSa, nNOSb, and nNOSc are 442, 134, and 151 bp in length, respectively. RT-PCR with isoform-specific sense and antisense primers located at various positions of the cDNA as well as direct sequencing of PCR products yielded no evidence for additional nNOS mRNA species or further variations within the coding sequence, except for a previously described 102-bp insert between exon 16 and 17 (23) that was detectable in skeletal muscle and embryo (data not shown). Comparative databank searches using the BLAST module showed that nNOSa shares a high degree of homology with one of the two alternative first exons identified in the mouse, while neither nNOSb nor nNOSc showed homology to any of the other alternative first exons described in mouse or human (17, 18) .
Tissue-and development-specific expression of nNOS mRNAisoforms. The expression pattern of the different transcriptional variants was determined by RNase protection assay using cDNA clones obtained by RACE as probes that included part of the published sequence corresponding to position ϩ 2 to ϩ 131. Because all three nNOS mRNA isoforms shared the additional common, newly recognized stretch of 30 bp in exon 2, a 160-bp fragment was expected to be protected, and was indeed found to be present in all tissues expressing any of the nNOS variants. In addition, specific transcript signals corresponding to the 5 Ј terminus of each nNOSa, nNOSb, and nNOSc, were found depending on tissue-specific isoform expression. Consistent with its high prevalence among RACE clones, nNOSa was the most abundant isoform. It showed highest expression in brain, followed by kidney, intestine, E18 embryo, adrenal, heart, and skeletal muscle. In contrast, nNOSb was exclusively expressed in E18 embryo, while nNOSc expression was found in kidney, skeletal muscle, and embryo (Fig. 2) . Absolute expression levels of nNOSc are low compared to the other isoforms, and signals were detectable only after prolonged exposure to autoradiographic material.
The only tissue that consistently tested negative for all three isoforms of nNOS was the testis.
Induction of nNOSa in terminally differentiated PC12 cells. Using sense primers A1, B1, and C1 specific for the alternative first exons in combination with the antisense primer N1 specific for exon 2 of the rat nNOS gene, RT-PCR followed by Southern blotting was carried out on cDNA obtained from rat pheochromocytoma-derived PC12 cells before and after induction of neuronal differentiation by NGF. While nNOS expression was almost undetectable under basal conditions, strong induction of nNOSa mRNA was seen in differentiating cells (Fig. 3) .
Physical mapping of the alternative first exons of the rat nNOS gene. PCR analyis using genomic DNA as template showed that all newly identified 5 Ј UTRs are encoded by a single exon, and are not interrupted by intronic sequences. Using primers anchored in exons 1c and 1b, the two exons were localized at a distance of 150 bp from each other, with exon 1c positioned upsteam of exon 1b. PCR pools of the rat YAC library were screened with primer pairs specific for the alternatively spliced exons (primer pairs Ay1/Ay2 for exon 1a and By1/By2 for exons 1b and 1c), as well as for the 5 Ј end (exon 2) and 3 Ј end of the published cDNA sequence. A single YAC (1.1 Mb) was found that gave rise to amplification products from all primer sets. Restriction mapping using infrequently cutting restriction endonucleases positioned exon 1a at a distance of at (Fig. 4) .
Discussion
Our results demonstrate that nNOS in the rat occurs in at least three isoforms characterized by the presence of different first exons, and that the previously published information regarding the 5 Ј end of what we now recognize as exon 2 of the rat nNOS cDNA was incomplete. In addition, we report that the three isoforms of the gene show markedly different expression patterns that are spatially and developmentally distinct. While the relative abundance of nNOS mRNA in the tissues analyzed is consistent with previous studies, our findings demonstrate that overall mRNA levels in some tissues are composed of different amounts of the mRNA variants of nNOS. Further studies using in situ hybridization are necessary to elucidate the spatial and temporal expression of nNOS-mRNA on a tissular and cellular level. These observations suggest a more complex and intricate pattern of modulation of expression for this enzyme than previously appreciated, and challenge the heretofore held perception that nNOS is a constitutively expressed gene.
The newly identified first exons 1a, 1b, and 1c of the rat nNOS gene are located upstream of the coding sequence, and therefore, do not result in a modification of the encoded protein. Recently, two nNOS mRNAs with alternative 5ЈUTRs were identified in the mouse as well as in humans (17, 18) . While rat nNOSa shows close homology to one of the mouse mRNA isoforms (nNOS␤), however, no similarity was detectable between nNOSb and nNOSc and the second 5ЈUTR (nNOS␥) in the murine nNOS gene. Likewise, no homology was found between any of the three first exons in the rat and the two reported alternative exons in humans (nNOS 5Ј and nNOS 5Ј2). This observation may simply reflect species-specific differences, or point to the presence of further yet to be identified alternative 5Ј ends in the rat that are homologous with the alternative first exon in mouse and the two human isoforms, and that may have escaped our present 5ЈRACE analysis due to low abundance. Although the heterogeneity of the 5Ј ends of nNOS mRNA could be explained by alternative splicing events, it is likely that activation of differential promoters is involved in their generation. In support of this, the two human nNOS mRNA species are thought to be transcribed from two closely linked, but separable promoters (17). , and nNOSc (C) were examined using 100 g total RNA from heart (H), testis (T), adrenal (A), intestine (I), kidney (K), brain (B), skeletal muscle (M), and E18 embryo (E); t, tRNA. The sizes of the protected fragments for nNOSa, nNOSb, and nNOSc were 319 bp, 278 bp, and 285 bp, respectively. Pa, Pb, and Pc indicate in vitro-transcribed probes that are 466, 410, and 381 bp, respectively, and included vector-encoded sequence. A protected fragment 160 bp in size corresponds to the common sequence shared by all isoforms. RT-PCR of RNA isolated from each of two dishes of PC12 cells without (ϪNGF) and with NGF treatment (ϩNGF). Sense primers A1, B1, and C1 (specific for nNOSa, nNOSb, and nNOSc, respectively) were combined with antisense primer N3 (see Fig. 1 ), and yielded fragment sizes of 202, 208, and 187 bp, respectively. Coϩ, positive control (cDNA pool derived from rat brain, kidney and embryo). CoϪ, negative control (H 2 O). Actin, 726-bp fragment of the rat ␤-actin cDNA.
Furthermore, the alternative use of multiple first exons flanked by tissue-specific promoters has been demonstrated for a number of other genes that are ubiquitously expressed, such as for the gene encoding aromatase (which, like nNOS, is a member of the cyotchrome P-450 superfamily) (24) and the gene encoding the glucocorticoid receptor (24) . The hypothesis that expression of nNOSb may be driven by a developmentally regulated promoter is consistent with its transient and exclusive expression during development (14, 15) . Our observation of developmentally specific expression patterns may shed some light on recent observations obtained in mice carrying a deletion of exon 2 of the nNOS gene (25) . We speculate that the relative absence of developmental pathology in this model may be explained by predominance of the still functional transcript nNOS␤ from the first alternative exon, that retains 85% activity during critical phases of development (18, 25) . The presence of multiple promoters would allow extensive regulation of transcription of a single gene both spatially and temporally, as suggested by the tissue-and development-specific expression pattern of nNOS mRNA species presented here.
Reminiscent of the two alternative first exons described in the human nNOS gene, exons 1c and 1b are located in close proximity to each other. A pattern search for the sequence juxtaposed between exons 1c and 1b revealed the presence of a number of consensus sequences such as those known to interact with nuclear factor-1, AP1, MyoD, GATA, and histoneH4. Any critical assessment concerning the functional relevance of these sequence elements and the characterization of putative promoters, however, must await the results of specific experiments.
Given the broad distribution of nNOS throughout the body and the extensive spectrum of biological functions mediated by NO, it would seem likely that the expression of this enzyme is regulated in a differentiated fashion. The use of alternative promoters is one mechanism that allows spatial-and temporalspecific regulation of transcription. The resulting complexity on the transcriptional level affords the organism the capacity to respond to numerous signals with a high degree of specificity. Thus, the level of the short-lived molecule NO in any given tissue is dependent not only on the calcium concentration, but also on a cell's specific endowment of trans-acting factors that control the relative level of expression of each of the known NO-producing enzymes. The identification of cis-and transacting factors that are responsible for the expression of the transcriptional variants of the nNOS gene will provide insight into the molecular mechanisms that control nNOS expression, and thus into the diversity of functional properties of nNOS in these tissues.
Increasing evidence suggests a role of 5Ј and 3ЈUTRs of mRNAs in the regulation of gene expression. Thus, so-called iron-responsive elements, found in 5ЈUTRs of genes involved in iron metabolism control their translational rate in response to changes of iron levels (26) . Certain sequences within the 3Ј-UTR have been shown to affect mRNA transport and stability (27) , and short open reading frames within 5ЈUTR have been implicated in the inhibition of translation (28). It is therefore certainly possible that variations in length or sequence of the 5ЈUTRs of the rat nNOS mRNA isoforms may affect nNOS protein levels via different posttranscriptional mechanisms.
NO has an extremely wide spectrum of functional properties that is unprecedented in biology. As one of the smallest water-and lipid-soluble carriers capable of chaperoning a free electron within and between cells, NO has access to a number of molecules, and is able to modify the state of active sites. It has been implicated in the regulation of ion channels, GTPases, and transcription factors (29) (30) (31) . To fulfill these multiple roles, a regulated mode of expression of nNOS, as supported by our findings, would appear reasonable, and, indeed perhaps essential.
Our observation of developmentally specific expression patterns of nNOS isoforms is compatible with emerging evidence that NO is involved in developmental processes such as apoptosis and differentiation. NO has been shown to trigger the switch to growth arrest during differentiation of PC12 cells into neuronal cells in response to NGF, a phenomenon that is accompanied by an induction of both calcium-independent and calcium-dependent NOS acitivity (20). Likewise, NO has been implicated as conferring antiproliferative effects during Drosophila development, controlling the balance between cell proliferation and cell differentiation (32) . Although the relevant NOS isozyme has not been specifically identified, dNOS, the only NOS-encoding gene cloned from Drosophila to date, shows strong homology to the mammalian nNOS (33) . Our finding that differentiation of PC12 cells into neurons is accompanied by the induction of nNOSa, the most abundant nNOS transcript found in the mature brain, is consistent with this proposed growth-or differentiation-regulating role of nNOS. In addition, since transcriptional activation of specific promoter elements by NGF in PC12 cells has been demonstrated for a number of genes, such as the genes encoding neuropeptide Y gene and transforming growth factor-beta gene (34, 35) , it seems reasonable to speculate that a similar mechanism may account for the specific induction of nNOSa.
In summary, we report original evidence that differential transcripts of nNOS show tissue-and development-specific expression patterns, and propose that this may represent a heretofore unrecognized mechanism of regulatory modulation of nNOS expression.
